Chamaeleo Pharma NV, a Belgium-based oncology company, has named Han Van ‘t Klooster as vice president of commercial operations. He will be a member of Chamaeleo’s management team and will be responsible for the market access and commercial launch of the company’s lead product Fosfestrol for the treatment of advanced prostate cancer. Mr. Van ‘t Klooster has over 20 years of business experience in the pharmaceutical industry. Prior to joining Chamaeleo, he was the general manager of Pharmion E...